Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Luigi Francesco
Effectiveness and safety of lasmiditan and rimegepant in the acute migraine treatment: an indirect real-world comparison
Study population The final cohort included 249 individuals (81.1% females, mean age 45.8 [95% CI 43.4–48.1] years, disease duration 29.7 [25.1–34.3] years), 58 participants from the DART study and 191 from the GAINER study. Diagnosis at enrolment was episodic migraine (EM) for 73.1% of participants (n = 182/249), and CM for 26.9% (n = 67/249), of whom 62.7% (n = 42/67) had a concomitant diagnosis of medication overuse headache (MOH).
Validation of the Italian version of the Cluster Headache Impact Questionnaire (CHIQ)
Neurological Sciences, Mar 2023 This is a preview of a remote PDF: https://link.springer.com/content/pdf/10.1007/s10072-023-06758-0.pdf Onofri, Agnese, Iannone, Luigi Francesco, Granato, Antonio, Garascia, Gabriele, Bartole, Luca, Manganotti, Paolo, Vollono, Catello, Romozzi, Marina, Sottani, Costanza, Calabresi, Paolo, Tassorelli, Cristina, Sances, Grazia, Allena, Marta, De Icco, Roberto, De Cesaris, Francesco, Burgalassi, Andrea, Chiarugi, Alberto, Baraldi, Carlo, Guerzoni, Simona,...
Human epidermal growth factor receptor 2 (HER2) in advanced gastric cancer: where do we stand? - Gastric Cancer
Abstract Gastric cancer is one of the most common malignancy worldwide. In unresectable or metastatic disease, the prognosis is poor and in generally less than a year. HER2 expression remains an important biomarker to lead the addition of trastuzumab to first-line systemic chemotherapy in unresectable or metastatic gastroesophageal adenocarcinoma.
Pharmacokinetic Interactions of Clinical Interest Between Direct Oral Anticoagulants and Antiepileptic Drugs
Introduction The direct-acting oral anticoagulants (DOACs), also known as non-vitamin K oral anticoagulants (NOACs), are five drugs acting on coagulation cascade, without the use of anti-thrombin as a mediator, subdivided in factor Xa inhibitors (apixaban, edoxaban, and rivaroxaban) and direct thrombin inhibitors (argatroban and dabigatran).
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Luigi
Contact Luigi, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack